Fundz

Miist Therapeutics raised $7M in seed funding led by Refactor Capital to develop instant-acting inhaled medicines for smoking addiction and migraines.

PRIVATEFeb 05, 2025

Amount Raised

$7 Million

Round Type

Seed

AlamedaBiotechnologyHealth CareMedicalTherapeutics

Investors

1517 FundFreeflow VenturesEntrepreneur FirstCalifornia Innovation FundRefactor Capital

Description

Miist Therapeutics announced $7M in seed funding to advance its clinically validated inhaled therapies, MST-01 and MST-02. The funding involves investors such as Refactor Capital and California Innovation Fund, supporting the development of rapid relief medicines for smoking addiction and migraines.

Quick answer

Miist Therapeutics raised $7 Million in a Seed round, dated February 5, 2025. Investors: 1517 Fund, Freeflow Ventures, Entrepreneur First, California Innovation Fund and Refactor Capital. Miist Therapeutics is based in Alameda, California, United States.

How much did Miist Therapeutics raise?
Miist Therapeutics raised $7 Million in a Seed round on February 5, 2025.
Who invested in Miist Therapeutics?
1517 Fund, Freeflow Ventures, Entrepreneur First, California Innovation Fund and Refactor Capital are named as investors in this round.
What does Miist Therapeutics do?
Miist Therapeutics applies a physics-based approach to develop inhaled therapies that are faster acting and more effective than today’s standard of care.
Where is Miist Therapeutics based and how big is it?
Miist Therapeutics is based in Alameda, California, United States. Fundz records about 5 employees.
Who are the decision-makers at Miist Therapeutics?
Fundz holds 2 contacts at Miist Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Miist Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
  • StimOxyGen raised $2M on March 11, 2025.
  • Monument Therapeutics raised $1.1M (Seed) on February 25, 2025.
  • Solid IO raised $839K (Seed) on February 24, 2025.
  • Ceretas raised $1M (Seed) on February 21, 2025.
  • MAIA Biotechnology raised $4.1M (Seed) on February 18, 2025.

Who to call at Miist Therapeutics, and when

A new round usually means Miist Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Miist Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Miist Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Miist Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Miist Therapeutics

Location

Alameda, California, United States

About

Miist Therapeutics applies a physics-based approach to develop inhaled therapies that are faster acting and more effective than today’s standard of care. The company’s core technology is an inhaler that uses ultrasonic vibration to generate and deliver 2-micron aqueous drug particles to the peripheral lung, where they are instantly absorbed into the bloodstream. Using this novel approach, Miist is developing new inhaled therapies that will deliver instant relief for some of our most common and debilitating conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Miist Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Miist Therapeutics's next move

See what Strategic adds

Miist Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.